Health Check: Running on empty, cash-strapped biotechs race for funding bowser
While this jalopy didn't quite make it to the bowser, cash-strapped biotechs are doing their best to top up their capital. Pic: Getty Images. Quarterly reports show that 32 out of 68 reporting biotechs had a cash runway of less than one year Overall …